Agreement - November 29, 2013
Egalet enters collaboration with Shionogi
Denmark’s Egalet has entered into a collaboration and license agreement with Shionogi. The collaboration and agreement regards the development and potential commercialization of multiple oral abuse-deterrent hydrocodone opioid product candidates using Egalet’s proprietary technology. Egalet will receive a $10 million upfront payment from Shionogi. Furthermore, Shionogi has agreed to purchase up to approximately $15 million in common stock in a private placement to […]
Biotech Award - November 29, 2013
Genmab wins award
Danish Genmab A/S has received the SCRIP Biotech Company of the Year award. The SCRIP awards celebrate the achievements of the international biopharmaceutical industry and were presented at an awards ceremony in London. “We are deeply honored to receive the Biotech Company of the Year award for the impressive advances we’ve made with our pipeline, proprietary innovative […]
Science Award - November 28, 2013
Professor Ola Winqvist awarded with Athena Prize
This year’s Athena Prize, the health care’s most prominent prize in clinical research, is awarded Professor Ola Winqvist and his research group at Karolinska Institutet. Winqvist is Professor of cellular immunotherapy at Karolinska Institutet and a chief physician at Karolinska University Hospital. Ola Winqvist and his co-workers have developed a new principle for the treatment […]
Collaboration - November 28, 2013
New European collaboration on vaccine
Several leading organizations are joining forces to launch a project to improve benefit and risk assesments of vaccines. The project will pave way for a pan-European framework for rapidly assessing and communicating the benefits and risks of vaccines. The hope is that the framework could make it easier for regulators and public health authorities to […]
Financing - November 27, 2013
Keytolead gets Vinnova funding
The start-up company Keytolead gets SEK 300 000 from the Vinnova funding program Vinn Nu. The Södertälje-based firm gets the funding to develop the work within early drug development. Keytolead runs pre-clinical research within the so-called lead generation phase. A total of 21 companies are getting funding from the program which is aimed at start-up […]
Uncategorized - November 26, 2013
New findings on retroviruses
By mapping endogenous retroviruses researchers at Uppsala University shine light on the evolutionary relationships of retroviruses. Through the use of large-scale computer analyses, researchers in Patric Jern’s research team at Science for Life Laboratory, Department of Medical Biochemistry and Microbiology at Uppsala University, have uncovered new depths in retroviral diversity and has found evidence for […]
